LIPO Lipella Pharmaceuticals Inc.
Fundamentals / CIK 0001347242 / USDLipella Pharmaceuticals Inc. reported $390K in revenue and a net loss of $5.33M for the trailing twelve months ended September 30, 2025 (down 100.0% year over year), with a -1387.9% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open LIPO in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue TTM$390K -100.0% YoY
-
Operating Income TTM-$5.41M -1387.9% margin
-
Net Income TTM-$5.33M -1367.4% net margin
-
Diluted EPS TTM-$1.17 Split-adjusted
-
Free Cash Flow TTM-- Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2025$1.86M Total debt: $264K
Annual revenue and net income
4 fiscal years (2021 to 2024), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|
| Revenue | $536K | $450K | $184K | $259K |
| Research & Development | $3.61M | $3.04M | $2.55M | $1.46M |
| Operating Income | -$5.08M | -$4.75M | -$2.59M | -$1.92M |
| EBITDA | -$5.08M | -$4.74M | -$2.59M | -$1.92M |
| Interest Income | $64K | $138K | $1.7K | $104 |
| Interest Expense | -- | $11K | $9.6K | $6.8K |
| Income Before Tax | -$5.02M | -$4.62M | -$2.60M | -$1.87M |
| Net Income | -$5.02M | -$4.62M | -$2.60M | -$1.87M |
| Basic EPS | -$4.79 | -$6.16 | -$5.12 | -$4.40 |
| Diluted EPS | -$4.79 | -$6.16 | -$5.12 | -$4.40 |
| Basic Shares Outstanding | 1.0M | 750.4K | 507.6K | 426.0K |
| Diluted Shares Outstanding | 1.0M | 750.4K | 507.6K | 426.0K |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $87K | $129K | $174K | $80K | $136K | $146K | $121K |
| Research & Development | $721K | $792K | $993K | $1.06M | $1.05M | $662K | $843K | $454K |
| Operating Income | -$1.27M | -$1.36M | -$1.33M | -$1.45M | -$1.46M | -$952K | -$1.22M | -$730K |
| EBITDA | -$1.27M | -$1.36M | -$1.33M | -$1.45M | -$1.46M | -$951K | -$1.22M | -- |
| Interest Income | $20K | $29K | $21K | $9.6K | $15K | $14K | $26K | $41K |
| Interest Expense | -- | -- | -- | -- | -- | -- | -- | $0 |
| Income Before Tax | -$1.25M | -$1.33M | -$1.31M | -$1.44M | -$1.44M | -$938K | -$1.19M | -$689K |
| Net Income | -$1.25M | -$1.33M | -$1.31M | -$1.44M | -$1.44M | -$938K | -$1.19M | -$689K |
| Basic EPS | -$0.28 | -$0.31 | -$0.64 | -- | -$1.29 | -$0.99 | -$1.31 | -- |
| Diluted EPS | -$0.28 | -$0.31 | -$0.64 | -- | -$1.29 | -$0.99 | -$1.31 | -- |
| Basic Shares Outstanding | 4.5M | 4.3M | 2.1M | -- | 1.1M | 950.7K | 911.5K | -- |
| Diluted Shares Outstanding | 4.5M | 4.3M | 2.1M | -- | 1.1M | 950.7K | 911.5K | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|
| Cash & Cash Equivalents | $2.18M | $3.29M | $5.12M | $1.41M |
| Short-Term Investments | -- | -- | -- | $301K |
| Cash & Short-Term Investments | $2.18M | $3.29M | $5.12M | $1.71M |
| Accounts Receivable, Net | $85K | $32K | $114K | -- |
| Total Current Assets | $2.62M | $3.43M | $5.80M | $1.81M |
| Property, Plant & Equipment, Net | $9.9K | $13K | -- | -- |
| Total Non-Current Assets | $57K | $148K | $151K | $205K |
| Total Assets | $2.67M | $3.58M | $5.95M | $2.01M |
| Accounts Payable | $388K | $138K | $384K | $47K |
| Other Current Liabilities | -- | -- | $250K | $25K |
| Total Current Liabilities | $754K | $385K | $1.18M | $341K |
| Other Non-Current Liabilities | -- | -- | -- | $50K |
| Total Non-Current Liabilities | $0 | $47K | $96K | $249K |
| Total Liabilities | $754K | $433K | $1.27M | $589K |
| Total Debt (incl. Leases) | $48K | $137K | $155K | $208K |
| Common Stock | $121 | $75 | $574 | $387 |
| Retained Earnings | -$15.34M | -$10.32M | -$5.70M | -$3.11M |
| Total Stockholders' Equity | $1.92M | $3.14M | $4.68M | $1.42M |
| Total Equity | $1.92M | $3.14M | $4.68M | $1.42M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $1.86M | $2.78M | $4.23M | $2.18M | $1.35M | $1.19M | $2.11M | $3.29M |
| Cash & Short-Term Investments | $1.86M | $2.78M | $4.23M | $2.18M | $1.35M | $1.19M | $2.11M | $3.29M |
| Accounts Receivable, Net | -- | -- | -- | $85K | $31K | $35K | $69K | $32K |
| Total Current Assets | $2.08M | $3.44M | $4.82M | $2.62M | $2.08M | $2.08M | $3.01M | $3.43M |
| Property, Plant & Equipment, Net | $7.7K | $8.4K | $9.1K | $9.9K | $11K | $11K | $12K | $13K |
| Total Non-Current Assets | $271K | $283K | $33K | $57K | $80K | $103K | $126K | $148K |
| Total Assets | $2.35M | $3.72M | $4.86M | $2.67M | $2.16M | $2.18M | $3.14M | $3.58M |
| Accounts Payable | $463K | $608K | $392K | $388K | $459K | $178K | $294K | $138K |
| Total Current Liabilities | $642K | $747K | $777K | $754K | $701K | $480K | $552K | $385K |
| Total Non-Current Liabilities | $220K | $232K | $1 | $0 | $0 | $0 | $24K | $47K |
| Total Liabilities | $862K | $979K | $777K | $754K | $701K | $480K | $576K | $433K |
| Total Debt (incl. Leases) | $264K | $275K | $24K | $48K | $71K | $94K | $24K | $137K |
| Common Stock | $462 | $446 | $254 | $121 | $109 | $761 | $704 | $75 |
| Retained Earnings | -$19.23M | -$17.97M | -$16.65M | -$15.34M | -$13.90M | -$12.45M | -$11.52M | -$10.32M |
| Total Stockholders' Equity | $1.49M | $2.74M | $4.08M | $1.92M | $1.46M | $1.70M | $2.56M | $3.14M |
| Total Equity | $1.49M | $2.74M | $4.08M | $1.92M | $1.46M | $1.70M | $2.56M | $3.14M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|
| Net Income | -$5.02M | -$4.62M | -$2.60M | -$1.87M |
| Depreciation & Amortization | $2.9K | $1.7K | $0 | $0 |
| Change in Payables | $250K | -$246K | $337K | $22K |
| Operating Cash Flow | -$3.95M | -$3.15M | -$1.83M | -$989K |
| Capital Expenditure | -- | -$14K | -- | -- |
| Free Cash Flow | -- | -$3.16M | -- | -- |
| Investing Cash Flow | -- | -$14K | $301K | -$301K |
| Common Stock Issued | -- | -- | $4.96M | $2.10M |
| Financing Cash Flow | $2.84M | $1.34M | $5.24M | $2.10M |
| Net Change in Cash | -$1.11M | -$1.83M | $3.71M | $807K |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$1.25M | -$1.33M | -$1.31M | -$1.44M | -$1.44M | -$938K | -$1.19M | -$689K |
| Depreciation & Amortization | $722 | $721 | $722 | $721 | $722 | $722 | $721 | -- |
| Change in Payables | -$145K | $216K | $3.9K | -$71K | $281K | -$115K | $156K | -$165K |
| Operating Cash Flow | -$926K | -$1.43M | -$1.43M | -$990K | -$653K | -$919K | -$1.39M | -$728K |
| Common Stock Issued | $0 | -$10K | $3.47M | -- | $820K | $0 | $200K | -- |
| Financing Cash Flow | $0 | -$10K | $3.47M | $1.82M | $820K | $0 | $200K | $1.61M |
| Net Change in Cash | -$926K | -$1.44M | $2.04M | $831K | $167K | -$919K | -$1.19M | $884K |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|
| Operating Margin | -947.2% | -1055.6% | -1406.3% | -738.7% |
| Net Profit Margin | -935.2% | -1027.3% | -1410.6% | -719.3% |
| Return on Equity (ROE) | -261.3% | -146.9% | -55.6% | -131.0% |
| Return on Assets (ROA) | -187.6% | -129.1% | -43.7% | -92.7% |
| Current Ratio | 3.47x | 8.90x | 4.92x | 5.31x |
| Quick Ratio | 3.01x | 8.63x | 4.44x | 5.03x |
| Debt to Equity | 0.02x | 0.04x | 0.03x | 0.15x |
| Revenue Growth (YoY) | +19.3% | +144.2% | -29.0% | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1387.9% | -1190.0% | -998.5% | -947.2% | -901.5% | -839.1% | -1021.9% | -1055.6% |
| Net Profit Margin | -1367.4% | -1174.1% | -987.0% | -935.2% | -881.7% | -816.7% | -993.4% | -1027.3% |
| Return on Equity (ROE) | -358.3% | -201.3% | -125.8% | -261.3% | -292.2% | -243.1% | -185.2% | -146.9% |
| Return on Assets (ROA) | -226.8% | -148.4% | -105.7% | -187.6% | -197.4% | -189.7% | -151.2% | -129.1% |
| Current Ratio | 3.24x | 4.60x | 6.21x | 3.47x | 2.97x | 4.33x | 5.46x | 8.90x |
| Quick Ratio | 2.89x | 3.72x | 5.44x | 3.01x | 1.97x | 2.54x | 3.94x | 8.63x |
| Debt to Equity | 0.18x | 0.10x | 0.01x | 0.02x | 0.05x | 0.05x | 0.01x | 0.04x |
| Revenue Growth (YoY) | -100.0% | -36.4% | -11.3% | +43.7% | -22.7% | +27.9% | +23.6% | -20.0% |